Csaba Farsang
Affiliations: | Semmelweis Egyetem, Hungary |
Area:
Molecular BiologyGoogle:
"Csaba Farsang"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dézsi CA, Glezer M, Karpov Y, et al. (2020) Effectiveness of Perindopril/Indapamide Single-Pill Combination in Uncontrolled Patients with Hypertension: A Pooled Analysis of the FORTISSIMO, FORSAGE, ACES and PICASSO Observational Studies. Advances in Therapy |
| Járai Z, Kolossváry E, Szabó I, et al. (2018) [The potential role of oscillometric devices for ankle-brachial index measurements in clinical practice]. Orvosi Hetilap. 159: 176-182 |
| Denardo SJ, Gong Y, Cooper-DeHoff RM, et al. (2015) Effects of verapamil SR and atenolol on 24-hour blood pressure and heart rate in hypertension patients with coronary artery disease: an international verapamil SR-trandolapril ambulatory monitoring substudy. Plos One. 10: e0122726 |
| Zanchetti A, Liu L, Mancia G, et al. (2014) Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial. Journal of Hypertension. 32: 1888-97 |
| Farsang C. (2013) Blood pressure and metabolic efficacy of fixed-dose combination of perindopril and indapamide in everyday practice. Blood Pressure. 22: 3-10 |
| Gupta M, Martineau P, Tran T, et al. (2012) Low-density lipoprotein cholesterol and high-sensitivity C-reactive protein lowering with atorvastatin in patients of South Asian compared with European origin: insights from the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST) study. Journal of Clinical Pharmacology. 52: 850-8 |
| Grassi G, Cifkova R, Laurent S, et al. (2011) Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study. European Heart Journal. 32: 218-25 |
| Farkas K, Fábián E, Kolossváry E, et al. (2011) Noninvasive assessment of endothelial dysfunction in essential hypertension: Comparison of the forearm microvascular reactivity with flow-mediated dilatation of the brachial artery International Journal of Angiology. 12: 224-228 |
| Farsang C, Naditch-Brule L, Avogaro A, et al. (2009) Where are we with the management of hypertension? From science to clinical practice. Journal of Clinical Hypertension (Greenwich, Conn.). 11: 66-73 |
| Blanco-Colio LM, MartÃn-Ventura JL, de Teresa E, et al. (2008) Atorvastatin decreases elevated soluble CD40L in subjects at high cardiovascular risk. Atorvastatin on inflammatory markers study: a substudy of ACTFAST. Kidney International. Supplement. S60-3 |